Introduction
Hypertension is a common disease that causes cardiovascular morbidity and mortality. In Japan, there are about 30 million patients with hypertension (Saito et al. 2000) . Although it is inferred that the genetic background of each individual plays a specific role in the pathogenesis of essential hypertension, concrete responsible genetic alterations are still unclear owing to their complex nature in polygenic, heterogeneous, and multifactorial disease. Therefore, we must clarify the genetic effects that cause hypertension to improve effective diagnosis for personalized medicine (Risch and Merikanges 1996; Lander 1996; Collins et al. 1997) .
Recently, attention has been focused on singlenucleotide polymorphisms (SNPs). SNPs are useful not only as markers for human genetic studies because of their high density, in every several hundred bases on average, throughout the human genome (Kruglyak 1999) , but also because they make it easy to perform large-scale genotyping by high-throughput methods (Ohnishi et al. 2001) . Furthermore, SNPs present in the coding region (coding SNPs; cSNPs) and promoter region (regulatory SNPs; rSNPs) of genes can potentially alter protein function and gene expression level, respectively (Collins et al. 1998; Cargill et al. 1999) . In particular, nonsynonymous substitution in the translated protein probably has an impact on protein function. Thus, identification of the nonsynonymous SNPs or rSNPs of genes responsible for common diseases will facilitate progress in methods of diagnosis.
Many biallelic and multiallelic polymorphisms in genes have been identified, and various association studies with hypertension have been performed (Benetos et al. 1996; Siffert et al. 1998; Glenn et al. 2000) . For instance, the Met235Thr variant of the human angiotensinogen gene has been found to be associated with an increased risk of hypertension (Jeunemaitre et al. 1992; Sato et al. 1997; Staessen et al. 1999) . Therefore, the presence of functional SNPs within the gene is likely. However, the number of wellcharacterized genes for hypertension is still limited, and T. Okuda · K. Kamide · Y. Kawano · Y. Goto · Y. Yoshimasa · H. Tomoike · N. Iwai · S. Hanai · T. Miyata (*) National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan Tel. ϩ81-6-6833-5012 ext. 2512; Fax ϩ81-6-6835-1176 e-mail: miyata@ri.ncvc.go.jp additional genes responsible for hypertension await identification. Furthermore, certain polymorphisms reflect ethnic diversity; therefore, the identification of SNPs in potential hypertension genes must be performed by taking into account the ethnicity of the sample population.
A large number of SNPs are deposited in the public database, dbSNP (Sherry et al. 1999 (Sherry et al. , 2001 , at the U.S. National Center for Biotechnology Information (NCBI). The SNPs stored in dbSNP are mostly "candidate" SNPs found by computer data-mining procedures and have not been characterized. Therefore, the SNPs in dbSNP must be validated before use. We considered that to identify potential hypertension genes, we needed to target mainly nonsynonymous cSNPs.
We report here a total of 159 SNPs in 93 hypertension candidate genes, detected among 64 chromosomes in Japanese population samples. To achieve this, we selected candidate genes for hypertension, then searched for candidate cSNPs in those genes by using the publicly available database dbSNP, and finally sequenced the genes to validate the SNPs. This strategy also revealed the limited availability of candidate SNPs in the publicly available database relevant to Japanese population samples. About 73% of the SNPs in the publicly available database were monomorphic in Japanese samples, and about 5% showed low frequency (less than 5%).
Materials and methods

Selection of hypertension candidate genes and SNPs
For the selection of hypertension candidate genes, we searched the OMIM database of NCBI by using the following 19 keywords; "hypertension," "essential hypertension," "blood pressure," "insulin resistance," "renin," "aldosterone," "angiotensin," "atherosclerosis," "obesity," "hypotension," "aging," "stroke," "renal failure," "vasoconstriction," "NIDDM," "cerebral infarction," "adrenaline," "cortisol," and "coronary artery disease." In addition, 75 hypertension candidate genes previously described by Halushka et al. (1999) were added. Thus, 505 hypertension candidate genes were obtained after removing duplicates. Next, we retrieved cSNPs in hypertension candidate genes from the publicly available database by using SNPper, a CHIP Bioinformatics Tool (Riva and Kohane 2001 ; http:// bio.chip.org:8080/bio, as of November of 2001). At this point, we had retrieved 560 candidate nonsynonymous cSNPs in 201 hypertension candidate genes for further study. We also obtained information on candidate SNPs from the JSNP (Hirakawa et al. 2002) and the SNP Consortium (TSC; http://snp.cshl.org/) databases.
Direct sequencing for verification of the cSNPs
We obtained peripheral blood samples from 32 volunteer Japanese with written informed consent. Genomic DNA was extracted with an NA-3000 nucleic acid isolation system 
Results
We selected 505 genes as hypertension candidate genes. Of these 505 genes, 367 were registered on SNPper. We focused on the nonsynonymous SNPs. Therefore, we retrieved using SNPper 560 nonsynonymous SNPs in 201 hypertension candidate genes for the sequence study. There were 115 synonymous SNPs in their vicinity that were also evaluated. We verified each SNP and its allele frequency among the 32 Japanese samples by single-pass DNA sequencing. We found that 150 SNPs failed PCR and/or sequencing, and 525 SNPs containing DNA fragments produced sequences of sufficient quality to evaluate the candidate SNP reliably (Table 1) . From this analysis, we found that 382 out of 525 SNPs (73%) were monomorphic; that is, only one of two predicted alleles was found in the The following SNPs were monomorphic among 32 Japanese individuals: rs1048098, rs1048096, rs1048095, rs1048094, rs4971, rs4972, (Table 2 ). In general, the new SNPs were present at low frequency. Ten new SNPs were observed in only one individual and two new SNPs were found in two individuals. We observed perfect linkage disequilibrium between two SNPs in eight genes (ACE, ADD1, EDNRA, F5, ICAM1, KLK1, PCSK1, RET) (Table 2 ). The genotypes of these two SNPs were completely concordant and generated only two haplotypes. Forty-three (30%) and 30 (21%) out of the 143 SNPs were registered in the JSNP database (Release 8) or the TSC database (Release 9), respectively.
Allele frequencies of SNPs are an important characteristic in defining their utility for human genetic application. The allele frequency distribution of 159 SNPs by the frequency of the minor allele is shown in Table 3 . Forty SNPs had a frequency between 1.0% and 5.0%, 56 had between 5.1% and 25.0%, and 63 had between 25.1% and 50.0%. We can estimate the prevalence of SNPs deposited in the dbSNP database by excluding the 16 new SNPs from the calculation. Thus, 10% and 12% of the SNPs deposited in the dbSNP database showed a minor allele frequency between 5.1% and 25.0% or between 25.1% and 50.0%, respectively. The allele frequencies obtained in this study were in good agreement with those in the JSNP database (Table 4) .
Discussion
We verified the hypertension candidate SNPs deposited in the publicly available database dbSNP by single-pass DNA sequencing to see if they represented true SNPs among Japanese population samples. To achieve this, we sequenced 32 samples from Japanese individuals. A total of 143 (27%) out of 525 SNPs retrieved from the publicly available database were confirmed. Our study also provided allele frequency information on SNPs in hypertension candidate genes. Our estimates indicated that approximately 20% of the SNPs deposited in the dbSNP database showed a minor allele frequency of over 5%. Therefore, if a researcher uses the candidate SNPs in the dbSNP for a Japanese population study, there is only about a 20% chance that the SNPs have appreciable minor allele frequency. These results show the limited utility of the publicly available SNPs for the Japanese population.
There are two independent efforts to experimentally identify SNPs. TSC is a nonprofit foundation organized for identifying SNPs distributed throughout the human genome. The SNPs identified by the TSC are deposited in the publicly available database by TSC number. In Release 9 of this database, 30 SNPs (21%) of the 143 SNPs we detected were registered. In Japan, JSNP is a repository of Japanese single-nucleotide polymorphism data (Hirakawa et al. 2002) , and the SNPs identified by resequencing 34 samples from anonymous Japanese individuals have been stored there. In Release 8 of this database (117,427 entries), 43 SNPs (30%) of the 143 SNPs we detected were registered. Furthermore, in the JSNP database, allele frequency information was supplemented for some SNPs by the latest release, Release 9, in January 2002. We compared the allele frequency of 12 SNPs between the JSNP data and ours (Table 4 ). The results showed that the allele frequency from our data was quite consistent with that from the JSNP data. dbSNP contains more than one million submissions from about 100 registered groups describing five species, including humans (Sherry et al. 1999; Sherry et al. 2001) . Submissions are divided into four categories, including those from SNP mining of the human genome project sequences (65%) and those from private investigator/corporate experimental results (28%). Public and private initiatives to discover new SNPs in humans identified more than 306,000 variations in the period 1999-2000 (Brookes et al. 2000) . We retrieved candidate SNPs from dbSNP without any preliminary screening. Had we retrieved only experimentally identified SNPs, as Marth et al. (2001) did, the monomorphic SNP sites would have been less frequent and confirmed SNPs would have been more prevalent. Marth et al. (2001) reported that more than 80% of TSC and Washington University (Taillon-Miller et al. 1998) candidate SNPs are polymorphic and that approximately 50% of the candidate SNPs from these two sources are common SNPs with a minor allele frequency of more than 20% (Marth et al. 2001 ).
In conclusion, we identified a total of 159 SNPs in 93 hypertension candidate genes among 64 chromosomes in samples from the Japanese population. These SNPs are extremely valuable for further association studies with hypertension.
